650 likes | 902 Views
ANTIHYPERTENSIVE Rx. MED PHARM 2010. Headlines of the St Louis Post-Dispatch April 13,1945. Messerli F. N Engl J Med 1995;332:1038-1039. Diastolic and Systolic Arterial Pressure of Franklin D. Roosevelt. Messerli F. N Engl J Med 1995;332:1038-1039. Risk Factors for Hypertension.
E N D
ANTIHYPERTENSIVE Rx MED PHARM 2010
Headlines of the St Louis Post-Dispatch April 13,1945 Messerli F. N Engl J Med 1995;332:1038-1039
Diastolic and Systolic Arterial Pressure of Franklin D. Roosevelt Messerli F. N Engl J Med 1995;332:1038-1039
Risk Factors for Hypertension Chobanian A. N Engl J Med 2009;361:878-887
Interaction of the Modern Western Diet and the Kidneys in the Pathogenesis of Primary Hypertension Adrogue H and Madias N. N Engl J Med 2007;356:1966-1978
Molecular Pathways Implicated in the Generation of Increased Arterial and Arteriolar Smooth-Muscle Tone by an Excess of Sodium and a Deficit of Potassium in Primary Hypertension Adrogue H and Madias N. N Engl J Med 2007;356:1966-1978
DRUGS FOR HYPERTENSION DIURETICS DIRECT VASODILATORS Thiazide – Type Hydralazine Hydrochlorothiazide Minoxidil Chlorthalidone Nitroprusside LOOP CENTRAL ALPHA-ADRENERGIC Furosemide AGONISTS Clonidine POTASSIUM – SPARING Triamterene CALCIUM CHANNEL BLOCKERS Verapamil Diltiazem Amlodopine
DRUGS FOR HYPERTENSION ALPHA-ADRENERGIC BETA-ADRENERGIC BLOCKERS BLOCKERS Prazosin Propranolol Metoprolol ALPHA –BETA BLOCKERS ANGIOTENSIN RECEPTOR Carvedilol ANTAGONISTS Labetalol Losartan ACE-Inhibitors RENIN ANTAGONISTS Benazepril Aliskiren
DIURETICS for HYPERTENSION Chlorthalidone Hydrochlorthiazide ADVERSE EFFECTS Fluid & electrolyte imbalance Hypokalemia Dysglycemia
Sites of Diuretic Action in the Nephron Ernst M and Moser M. N Engl J Med 2009;361:2153-2164
aPotential Complications of DiureticAAAAs nd Their Associated Mechanisms Ernst M and Moser M. N Engl J Med 2009;361:2153-2164
Regulation of Vascular Smooth-Muscle Tone Landry D and Oliver J. N Engl J Med 2001;345:588-595
CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS CLONIDINE
CLONIDINE • Central a2 agonist • Hemodynamics Decrease in : Cardiac output Systemic vascular resistance
ALPHA- ADRENERGIC ANTAGONISTS PRAZOSIN Hemodynamics Decrease in systemic vascular resistance ADVERSE RESPONSE first dose hypotension
BETA ADRENERGIC ANTAGONISTS • Propranolol non-selective • Metoprololcardioselective, b1 block Beta blockers are not as effective as the other 4 classes of drugs in reducing stroke, particularly in the elderly
BETA BOCKERS – ADVERSE EFFECTS CNS Cardiovascular Bad dreams Aggravation of severe CHF Depression Aggravation of occlusive arterial disease Slow A-V conduction Pulmonary Bronchospasm in Asthmatics Drug interactions Drugs that impair A-V conduction (digoxin and some calcium channel blockers)
VASODILATORS FOR HYPERTENSION HYDRALAZINE MINOXIDIL SODIUM NITROPRUSSIDE
HYDRALAZINE A direct acting vasodilator May prevent oxidation of NO Hemodynamics- Decrease in systemic vascular resistance
HYDRALAZINE Adverse Effects Fluid retention Lupus-like syndrome in slow acetylators Reflex tachycardia
ACTION: HEMODYNAMIC ACTIONS: ADVERSE EFFECTS: Direct acting peripheral vasodilator for resistant hypertension Decrease in systemic vascular resistance Fluid retention, Tachycardia, Angina, Pericardial effusion, Hirsutism, EKG changes MINOXIDIL
Regulation of the Relaxation of Vascular Smooth Muscle by Nitric Oxide Griffiths, M. J.D. et al. N Engl J Med 2005;353:2683-2695
Regulation of Vascular Smooth-Muscle Tone Landry D and Oliver J. N Engl J Med 2001;345:588-595
SODIUM NITROPRUSSIDE ACTION Direct relaxation of all vascular smooth muscle Balanced arteriolar and venous dilation Decrease in systemic vascular resistance Intravenous administration USES Hypertensive crisis Heart failure
RAAS ANGIOTENSIN II FORMATION
The angiotension II types 1 (AT 1 ) and 2 (AT 2 ) receptors have generally opposing effects Oparil, S. et. al. Ann Intern Med 2003;139:761-776
Actions of Angiotensin II Goodfriend, T. L. et al. N Engl J Med 1996;334:1649-1655
BENAZEPRIL A Long-acting Inhibitor of Angiotensin Converting Enzyme
ACTION: HEMODYNAMIC EFFECT: ADVERSE EFFECTS: Inhibits angiotensin converting enzyme, to reduce formation of angiotensin II and aldosterone, inhibits lysis of bradykinin, may alter prostaglandin metabolism and sympathetic transmission. Decreases total peripheral resistance Heart rate and cardiac output unchanged Cough, angioedema, teratogenic, neutropenia, agranulocytosis, loss of taste, skin rash,& hypotension BENAZEPRIL
ACEI & ARB TERATOGENICITY 1st half ~2.7X increase in malformations CV & CNS 2nd half oligohydramnios growth retardation pulmonary hypoplasia renal failure hypotension death
ANGIOTENSIN RECEPTOR ANTAGONISTS ( ARBs) LOSARTAN OTHERS
Signal Transduction by Angiotensin AT1 Receptors Goodfriend T et al. N Engl J Med 1996;334:1649-1655
The angiotension II types 1 (AT 1 ) and 2 (AT 2 ) receptors have generally opposing effects Oparil, S. et. al. Ann Intern Med 2003;139:761-776
RAASRENIN ANTAGONIST • ANGIOTENSIN II FORMATION
ALISKIREN Renin inhibitor Lowers blood pressure Outcome studies-none
CALCIUM CHANNEL BLOCKERS Verapamil Diltiazem Amlododipine